Platelet activation and mitral valve prolapse
Fisher, Marc ; Weiner, Bonnie H. ; Ockene, Ira S. ; Forsberg, Ann D. ; Duffy, Celeste P. ; Levine, Peter H.
Fisher, Marc
Weiner, Bonnie H.
Ockene, Ira S.
Forsberg, Ann D.
Duffy, Celeste P.
Levine, Peter H.
Citations
Altmetric:
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Journal Article
Publication Date
1983-03-01
Keywords
Adolescent
Adult
Aged
Blood Coagulation Factors
Blood Platelets
Cerebrovascular Disorders
Female
Humans
Male
Middle Aged
Mitral Valve Prolapse
Platelet Factor 4
Risk
Hemostasis
F1+2
P-selectin
platelets
mitral valve prolapse
Cardiology
Cardiovascular Diseases
Cells
Diagnosis
Hemic and Immune Systems
Adult
Aged
Blood Coagulation Factors
Blood Platelets
Cerebrovascular Disorders
Female
Humans
Male
Middle Aged
Mitral Valve Prolapse
Platelet Factor 4
Risk
Hemostasis
F1+2
P-selectin
platelets
mitral valve prolapse
Cardiology
Cardiovascular Diseases
Cells
Diagnosis
Hemic and Immune Systems
Subject Area
Embargo Expiration Date
Link to Full Text
Abstract
Mitral valve prolapse (MVP) is a predisposing factor for cerebral ischemia, especially in young adults. Cerebral embolization of intracardiac thrombi is the probable mechanism in many cases. Platelets play a key role in the development of thrombi. We found that platelet factor 4, a marker protein of platelet activation, was elevated in 12 of 33 MVP patients (36%) without a history of stroke. This finding indicates that platelets are frequently activated in asymptomatic MVP patients and may allow identification of a subgroup of MVP patients with activated platelets who are at increased risk for emboli.
Source
Neurology. 1983 Mar;33(3):384-6.
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1212/wnl.33.3.384
Permanent Link to this Item
PubMed ID
6681886